लोड हो रहा है...
Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemia
We evaluated pomalidomide with prednisone for myelofibrosis (MF) with significant anemia (hemoglobin <10g/dL). Patients (n=29; 18 RBC-transfusion dependent) received 0.5 mg pomalidomide daily in continuous 28-day cycles with prednisone given for the first 3 cycles only. Six (21%) patients respond...
में बचाया:
| मुख्य लेखकों: | , , , , , , , , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2014
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4157096/ https://ncbi.nlm.nih.gov/pubmed/25047979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2014.06.015 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|